If you need a more accessible version of this website, click this button on the right. Switch to Accessible Site

WARNING

You are using an outdated browser. Please upgrade your browser to improve your experience.

Close [x]

Call Us Today

818-552-5040
m

Sign up or call 818-552-5040/310-659-2200 to make an appointment.

Kent W. Small, MD

Board-Certified: American Board of Ophthalmology

Fellowship: Vitreoretinal Diseases and Surgery, Duke University Eye Center, Durham, NC; Molecular Genetics, Duke University School of Medicine, Durham, NC

MD: Tulane University School of Medicine, New Orleans, LA

Specialized care for retinal diseases:

  • Macular degeneration
  • Diabetic retinopathy
  • Retinal tears & detachments
  • Inherited retinal diseases
  • Retinal vascular disease
  • Macular holes
  • Macular puckers
  • Macular edema
  • Proliferative vitreoretinopathy/scar tissue

State-of-the-art diagnostic exams:

  • Fluorescein & indocyanine green (ICG) angiography
  • Fundus photography
  • Scanning laser ophthalmoscopy (SLO)
  • Ultrasound A & B scans
  • Visual field testing
  • Microperimetry
  • Optical coherence tomography (OCT)

Anti-VEGF Treatment for Non-AMD Disease

Researchers have found that a chemical called vascular endothelial growth factor, or VEGF, is critical in causing abnormal blood vessels to grow under the retina. Scientists have developed several new drugs that can block the trouble-causing VEGF known as “anti-VEGF” drugs. They help block abnormal blood vessels, slow their leakage, and help reduce vision loss.

Certain anti-VEGF treatments are approved for a condition known as “wet” age-related macular degeneration (AMD), in which abnormal blood vessels grow underneath the retina. These unhealthy vessels leak blood and fluid that can swell and scar the macula (the central part of the retina), and vision loss may be rapid and severe.

Since anti-VEGF therapies have shown good potential for slowing vascular leakage and preventing vision loss associated with wet AMD, ophthalmologists (Eye M.D.s) are using them to treat other causes of macular edema. If your ophthalmologist has diagnosed you with diabetic retinopathy, retinal venous occlusion, or other conditions, you may benefit from anti-VEGF treatment if other therapies are not producing the desired results or if your ophthalmologist thinks that anti-VEGF therapy is the best first course of action.

Treatment with the anti-VEGF drug is usually performed by injecting the medicine with a very fine needle into the back portion of your eye. Your ophthalmologist will clean your eye to prevent infection and will administer an anesthetic into your eye to reduce pain. Usually, patients receive multiple anti-VEGF injections over the course of many months. There is a small risk of complications with anti-VEGF treatment, usually resulting from the injection itself. However, for most people, the benefits of this treatment outweigh the small risk of complications.

Cedars-Sinai medical towers | 8635 West 3rd Street, Suite 395-W, Los Angeles, CA 90048 | Tel: (310) 659-2200 | Fax: (310) 659-2822 Glendale Office | 501 North Orange Street Suite 250, Glendale, CA 91203 | Tel: (818) 552-5040 | Fax: (818) 552-5044

Services
We strive to provide complete care for our patients. Learn more about all the services we provide.
Make An Appointment
We will do our best to accommodate your busy schedule. Schedule an appointment today!
Online Forms
Our patient forms are available online so they can be completed in the convenience of your own home or office.